- Presentations
- 2
- Markets
- 1
Tresiba is a brand of Insulin degludec marketed by Novo Nordisk, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Insulin degludec
- Brand owner
- Novo Nordisk
- Registered in
- United States
- Strengths and forms
- 100 units/mL injection, 200 units/mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tresiba 100 units/mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
| Tresiba 200 units/mL injectionSubcutaneous | Novo Nordisk | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tresiba
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.